Document Detail


Beta1- or beta2-blockers to improve hemodynamics following endotracheal adrenaline administration.
MedLine Citation:
PMID:  16086554     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The recommended dose for endotracheal adrenaline (0.02 mg/kg) causes a pronounced initial decrease in diastolic blood pressure which is detrimental at the initial phase of cardiopulmonary resuscitation. This effect was previously attributed to an early and preferential stimulation of the beta-adrenergic receptors causing vasodilatation unopposed by an alpha-adrenergic vasoconstriction. We hypothesized that inhibition of the beta2-adrenoreceptors is responsible for prevention of the deleterious initial decrease in blood pressure that takes place following endotracheal administration of adrenaline. METHODS: Adrenaline (0.02 mg/kg) diluted with normal saline (5 ml) was injected into the endobronchial tree of anesthetized dogs 3 min following pretreatment with the non-selective beta-blocker propranolol, selective beta1-blocker metoprolol (0.1 mg/kg, i.v.), or without pre-treatment. Heart rate, blood pressure and arterial blood gases were monitored. RESULTS: The selective beta-blocker metoprolol was almost as effective as the non-selective beta-blocker propranolol in attenuating the initial decrease in blood pressure following endotracheally administered adrenaline, a phenomenon that was previously attributed to inhibition of beta-adrenoreceptors. CONCLUSIONS: The outcome of this study might be explained by a dose-related loss of cardioselectivity of metoprolol. Further studies are warranted to refine the pharmacological means to abort the initial blood pressure-lowering effect of endotracheally administered adrenaline.
Authors:
Ron Ben-Abraham; David Stepensky; Yudith Assoulin-Dayan; Ori Efrati; Danny Lotan; Yossi Manisterski; Mati Berkovitch; Zohar Barzilay; Gideon Paret
Related Documents :
2571664 - Abrupt change from a beta-adrenoceptor blocking drug to enalapril in hypertension.
8234574 - Anger suppression: its relationship to beta-adrenergic receptor sensitivity and stress-...
2532964 - Chronic paroxysmal hemicrania: a chronobiological study (case report).
24689424 - Pressure ulcer prevention.
9533424 - Evaluation of changes in sympathetic nerve activity and heart rate in essential hyperte...
9178374 - Cardiorespiratory effects of l-glutamate microinjected into the rat ventral medulla.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug metabolism and drug interactions     Volume:  21     ISSN:  0792-5077     ISO Abbreviation:  Drug Metabol Drug Interact     Publication Date:  2005  
Date Detail:
Created Date:  2005-08-09     Completed Date:  2005-12-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8904736     Medline TA:  Drug Metabol Drug Interact     Country:  England    
Other Details:
Languages:  eng     Pagination:  31-9     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology and Critical Care, Tel Aviv Sourasky Medical Center, Tel Hashomer, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology*
Animals
Blood Pressure / drug effects*
Dogs
Epinephrine / administration & dosage*
Female
Heart Rate / drug effects
Injections
Male
Metoprolol / pharmacology*
Propranolol / pharmacology*
Trachea
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 37350-58-6/Metoprolol; 51-43-4/Epinephrine; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preventing hepatocyte oxidative stress cytotoxicity with Mangifera indica L. extract (Vimang).
Next Document:  Involvement of nitric oxide in clonidine-induced spinal analgesia.